MacGuire Cheswick & Tuttle Investment Counsel’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$4.41M Sell
68,873
-4,200
-6% -$310K 0.92% 34
2018
Q3
$6.54M Sell
73,073
-1,730
-2% -$153K 1.12% 36
2018
Q2
$5.94M Sell
74,803
-9,398
-11% -$780K 1.09% 36
2018
Q1
$7.51M Sell
84,201
-1,210
-1% -$116K 1.4% 25
2017
Q4
$8.91M Sell
85,411
-2,360
-3% -$266K 1.62% 25
2017
Q3
$12.8M Buy
87,771
+450
+0.5% +$61.3K 2.51% 16
2017
Q2
$11.3M Sell
87,321
-5,053
-5% -$619K 2.3% 18
2017
Q1
$11.5M Buy
92,374
+2,370
+3% +$284K 2.23% 20
2016
Q4
$10.4M Buy
90,004
+5,785
+7% +$644K 2.15% 20
2016
Q3
$8.8M Buy
84,219
+2,760
+3% +$299K 1.97% 22
2016
Q2
$8.03M Buy
81,459
+7,867
+11% +$814K 1.79% 24
2016
Q1
$7.37M Buy
73,592
+2,200
+3% +$227K 1.71% 26
2015
Q4
$8.55M Buy
71,392
+1,350
+2% +$156K 1.92% 23
2015
Q3
$7.58M Sell
70,042
-3,295
-4% -$409K 1.85% 25
2015
Q2
$8.49M Buy
73,337
+425
+0.6% +$48.6K 1.9% 27
2015
Q1
$8.4M Sell
72,912
-712
-1% -$85.1K 1.9% 25
2014
Q4
$8.24M Buy
73,624
+850
+1% +$89.6K 1.85% 24
2014
Q3
$6.9M Buy
72,774
+70
+0.1% +$6.32K 1.61% 29
2014
Q2
$6.24M Sell
72,704
-440
-0.6% -$33.5K 1.45% 30
2014
Q1
$5.11M Buy
73,144
+3,816
+6% +$302K 1.24% 34
2013
Q4
$5.86M Buy
69,328
+55,720
+409% +$4.41M 1.41% 28
2013
Q3
$1.05M Buy
13,608
+4,208
+45% +$295K 0.29% 59
2013
Q2
$550K Buy
+9,400
New +$566K 0.16% 69

Other funds holding CELG

MacGuire Cheswick & Tuttle Investment Counsel's CELG Position: Q4 2018 in Review

MacGuire Cheswick & Tuttle Investment Counsel reduced its Celgene Corp (CELG) stake by 5.7% in Q4 2018, selling an estimated $310K and leaving 68,873 shares worth $4.41M. The position accounts for 0.92% of the portfolio, ranked #34.

MacGuire Cheswick & Tuttle Investment Counsel first reported a position in CELG in Q2 2013 and has held it in 23 quarters since. The position peaked at $12.8M in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • MacGuire Cheswick & Tuttle Investment Counsel held 68,873 shares of Celgene Corp worth $4.41M as of Q4 2018.
  • MacGuire Cheswick & Tuttle Investment Counsel sold 4,200 Celgene Corp shares in Q4 2018, an estimated $310K.
  • Celgene Corp made up 0.92% of MacGuire Cheswick & Tuttle Investment Counsel's portfolio in Q4 2018, its #34 holding.
  • MacGuire Cheswick & Tuttle Investment Counsel first reported a position in Celgene Corp in Q2 2013 and has held it in 23 quarters since.
  • MacGuire Cheswick & Tuttle Investment Counsel's Celgene Corp position peaked at $12.8M in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on MacGuire Cheswick & Tuttle Investment Counsel's 13F filing for Q4 2018, filed 11 Feb 2019.